Scarica l'app Stockscreener
4.07
0.25%
-0.010
Precedente Chiudi:
$4.08
Aprire:
$4.125
Volume 24 ore:
2.70M
Relative Volume:
0.66
Capitalizzazione di mercato:
$547.72M
Reddito:
-
Utile/perdita netta:
$-217.44M
Rapporto P/E:
-1.8756
EPS:
-2.17
Flusso di cassa netto:
$-205.20M
1 W Prestazione:
+9.41%
1M Prestazione:
+17.63%
6M Prestazione:
+113.09%
1 anno Prestazione:
+0.49%
Intervallo 1D:
$3.9401
$4.125
Intervallo di 1 settimana:
$3.6801
$4.18
Portata 52W:
$1.11
$5.17
Prime Medicine Inc Stock (PRME) Company Profile
Nome
Prime Medicine Inc
Settore
Industria
Telefono
617-465-0013
Indirizzo
60 FIRST ST., CAMBRIDGE
Confronta PRME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
4.07 | 693.49M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-05-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-12-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-20 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-22 | Iniziato | Chardan Capital Markets | Buy |
| 2024-04-08 | Iniziato | TD Cowen | Buy |
| 2024-04-03 | Iniziato | Wedbush | Outperform |
| 2024-01-16 | Downgrade | Stifel | Buy → Hold |
| 2023-12-08 | Iniziato | Citigroup | Neutral |
| 2023-10-09 | Iniziato | BMO Capital Markets | Outperform |
| 2023-07-31 | Iniziato | Guggenheim | Buy |
| 2023-04-18 | Iniziato | Stifel | Buy |
| 2022-11-14 | Iniziato | Goldman | Neutral |
| 2022-11-14 | Iniziato | JP Morgan | Overweight |
| 2022-11-14 | Iniziato | Jefferies | Buy |
| 2022-11-14 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Prime Medicine Inc Borsa (PRME) Ultime notizie
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN
Is Prime Medicine Inc. backed by strong institutional buyingStop Loss & Free High Accuracy Swing Entry Alerts - Lancaster City Council
Prime Medicine Unveils New Prime Editing Advancements - TipRanks
Prime Medicine Inc. Breaks Losing Streak — Is the Trend ReversingJuly 2025 Institutional & Smart Allocation Stock Tips - beatles.ru
Prime Medicine (NASDAQ:PRME) Stock Price Down 3.7% After Analyst Downgrade - MarketBeat
What is Prime Medicine Inc.’s market position2025 Macro Impact & Advanced Swing Trade Entry Alerts - 뉴스영
Best data tools to analyze Prime Medicine Inc. stock2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Can Prime Medicine Inc. disrupt its industryAnalyst Upgrade & Step-by-Step Trade Execution Guides - خودرو بانک
Is Prime Medicine Inc. stock reversal real or fakeJuly 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Why is Prime Medicine Inc. stock going up2025 Trade Ideas & Safe Entry Point Identification - خودرو بانک
Analyzing Prime Medicine Inc. with multi timeframe chartsProfit Target & Consistent Profit Alerts - Newser
How to read the order book for Prime Medicine Inc.CEO Change & Weekly Watchlist for Hot Stocks - Newser
How moving averages guide Prime Medicine Inc. tradingJuly 2025 Technicals & High Conviction Buy Zone Alerts - Newser
What data driven models say about Prime Medicine Inc.’s futureStock Surge & Risk Managed Investment Strategies - Newser
What’s Prime Medicine Inc.’s historical returnIPO Watch & Precise Buy Zone Tips - khodrobank.com
Is a relief rally coming for Prime Medicine Inc. holdersWeekly Stock Summary & Expert Verified Movement Alerts - Newser
Market reaction to Prime Medicine Inc.’s recent news2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
Is Prime Medicine Inc. forming a breakout pattern2025 Top Decliners & Low Risk Entry Point Guides - خودرو بانک
Is this a good reentry point in Prime Medicine Inc.Earnings Summary Report & AI Driven Price Predictions - Newser
Will Prime Medicine Inc. stock go up soonProfit Target & Technical Pattern Based Signals - Newser
Strategies to average down on Prime Medicine Inc.Trade Analysis Report & Risk Controlled Daily Trade Plans - Newser
How hedge fund analytics apply to Prime Medicine Inc. stockMarket Risk Analysis & Reliable Price Action Trade Plans - Newser
Visual trend scoring systems applied to Prime Medicine Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
What is Prime Medicine Inc. s revenue forecastGap Down & Verified Swing Trading Watchlist - خودرو بانک
Prime Medicine, Inc. shares rise 7.85% intraday after presenting at Citi's Biopharma Back to School event. - AInvest
Can a trend reversal in Prime Medicine Inc. lead to recovery2025 Winners & Losers & Comprehensive Market Scan Insights - Newser
Can machine learning forecast Prime Medicine Inc. recoveryMarket Movers & Consistent Growth Equity Picks - Newser
Will Prime Medicine Inc. continue its uptrendMarket Trend Report & Consistent Income Trade Ideas - Newser
What moving averages say about Prime Medicine Inc.Portfolio Risk Report & Reliable Entry Point Trade Alerts - Newser
Multi asset correlation models including Prime Medicine Inc.2025 Volatility Report & Community Shared Stock Ideas - Newser
Prime Medicine to Participate in Upcoming Investor Conferences - 富途牛牛
Can volume confirm reversal in Prime Medicine Inc.July 2025 Selloffs & Intraday High Probability Setup Alerts - Newser
Evaluating Prime Medicine Inc. with trendline analysis2025 Year in Review & Risk Controlled Swing Trade Alerts - Newser
Prime Medicine Inc. stock trendline breakdownWeekly Stock Report & Low Volatility Stock Recommendations - Newser
Prime Medicine Inc. Recovery Hinges on Volume BreakoutJuly 2025 Action & High Return Trade Opportunity Guides - beatles.ru
Can Prime Medicine Inc. reach resistance levels soonJuly 2025 Intraday Action & Weekly Sector Rotation Insights - خودرو بانک
Is Prime Medicine Inc. exposed to political riskMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Is Prime Medicine Inc. stock a good pick for beginnersEarnings Trend Report & Reliable Price Breakout Signals - خودرو بانک
Aug Macro: Is Prime Medicine Inc. forming a breakout patternJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
What’s the profit margin of Prime Medicine Inc.Portfolio Performance Summary & Daily Stock Trend Watchlist - خودرو بانک
Will Prime Medicine Inc. bounce back from current supportJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
PRME.O Drops 5.8% on Technical Weakness Amid Mixed Peer Activity - AInvest
Prime Medicine (PRME.O) Faces Sharp Intraday Drop Despite No New Fundamental News - AInvest
Advanced analytics toolkit walkthrough for Prime Medicine Inc.Breakout Watch & Risk Controlled Stock Pick Alerts - Newser
Prime Medicine Inc Azioni (PRME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Prime Medicine Inc Azioni (PRME) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT | Director |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| ARCH Venture Partners XII, LLC | 10% Owner |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| ARCH Venture Partners X, LLC | 10% Owner |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| Liu David R. | 10% Owner |
Jun 30 '25 |
Buy |
2.52 |
21,000 |
52,830 |
20,240,945 |
| Liu David R. | 10% Owner |
Jun 23 '25 |
Buy |
2.16 |
21,000 |
45,402 |
20,219,945 |
| Liu David R. | 10% Owner |
Jun 16 '25 |
Buy |
1.49 |
21,000 |
31,196 |
20,198,945 |
| Liu David R. | 10% Owner |
Jun 11 '25 |
Buy |
1.60 |
21,000 |
33,590 |
20,177,945 |
| Brudnick Richard | Chief Business Officer |
May 20 '25 |
Buy |
1.19 |
20,000 |
23,790 |
20,000 |
| LEE ANN L. | Chief Technical Officer |
May 21 '25 |
Buy |
1.13 |
100,000 |
113,000 |
100,000 |
| Reine Allan | Chief Executive Officer |
May 21 '25 |
Buy |
1.18 |
125,000 |
147,150 |
125,000 |
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):